Cisatracurium Besylate
NDC 0143-9160, Cisatracurium Besylate, injection, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0143-9160
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203078
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0143-9160-10 | 00143916010 | 10 VIAL in 1 CARTON (0143-9160-10) / 20 mL in 1 VIAL (0143-9160-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c5a63679-0c94-4e9d-9ac0-8ee3023bd9a6
Use it
Look up 0143-9160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0143-9160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.